Last reviewed · How we verify
PATANASE nasal spray
PATANASE nasal spray is a Small molecule drug developed by Glenmark Pharmaceuticals Ltd. India. It is currently in Phase 2 development.
At a glance
| Generic name | PATANASE nasal spray |
|---|---|
| Sponsor | Glenmark Pharmaceuticals Ltd. India |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Azelastine Allergen Chamber - Onset of Action Study (PHASE2)
- A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis (PHASE4)
- Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes
- To Study GSP 301 in Patients With Seasonal Allergic Rhinitis (PHASE2)
- Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) (PHASE3)
- Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) (PHASE3)
- Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) (PHASE3)
- Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PATANASE nasal spray CI brief — competitive landscape report
- PATANASE nasal spray updates RSS · CI watch RSS
- Glenmark Pharmaceuticals Ltd. India portfolio CI
Frequently asked questions about PATANASE nasal spray
What is PATANASE nasal spray?
PATANASE nasal spray is a Small molecule drug developed by Glenmark Pharmaceuticals Ltd. India.
Who makes PATANASE nasal spray?
PATANASE nasal spray is developed by Glenmark Pharmaceuticals Ltd. India (see full Glenmark Pharmaceuticals Ltd. India pipeline at /company/glenmark-pharmaceuticals-ltd-india).
What development phase is PATANASE nasal spray in?
PATANASE nasal spray is in Phase 2.
Related
- Manufacturer: Glenmark Pharmaceuticals Ltd. India — full pipeline
- Compare: PATANASE nasal spray vs similar drugs
- Pricing: PATANASE nasal spray cost, discount & access